Westlund P et al. |
Identification of 11-dehydro-TXB2 as a suitable parameter for monitoring thromboxane production in the human. |
1986 |
Prostaglandins |
pmid:3755250
|
Westlund P et al. |
Circulating and urinary thromboxane B2 metabolites in the rabbit: 11-dehydro-thromboxane B2 as parameter of thromboxane production. |
1986 |
Prostaglandins |
pmid:3520685
|
d'Emmanuele di Villa Bianca R et al. |
Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24019484
|
McAdam BF et al. |
Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9874808
|
Catella F et al. |
11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. |
1986 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:3461463
|
Montine TJ et al. |
Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT. |
2010 |
PLoS ONE |
pmid:20174466
|
Gremmel T et al. |
Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation. |
2011 |
Platelets |
pmid:21231857
|
Frisbee JC et al. |
Aspirin resistance with genetic dyslipidemia: contribution of vascular thromboxane generation. |
2010 |
Physiol. Genomics |
pmid:20530721
|
Hart RG et al. |
Aspirin dosage and thromboxane synthesis in patients with vascular disease. |
2003 |
Pharmacotherapy |
pmid:12741431
|
Saareks V et al. |
Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. |
2002 |
Pharmacol. Toxicol. |
pmid:12403056
|